Surgical Tissue Flap for Glioblastoma
Trial Summary
The surgical tissue flap treatment for glioblastoma is unique because it uses a patient's own tissue (autograft) from the temporoparietal fascial or pericranial area to repair and reconstruct areas affected by the tumor. This approach is different from standard treatments like chemotherapy or radiation, as it focuses on physical reconstruction and healing using the body's own tissues, which can provide a well-vascularized (good blood supply) and thin layer ideal for repair.
13578The surgical tissue flap, known as the temporoparietal fascial flap (TPFF), has been used safely in various head and neck reconstructions, including repairing facial defects and cerebrospinal fluid leaks, with no reported complications in the studies reviewed.
12356The temporoparietal fascial flap (TPFF) has been effectively used in head and neck reconstructions, such as repairing cerebrospinal fluid leaks and reconstructing facial defects, due to its good blood supply and proximity to the surgical site. These properties suggest it could be beneficial in glioblastoma surgery by providing well-vascularized tissue to support healing.
13456The trial information does not specify whether you need to stop taking your current medications. However, if you have started chemotherapy or radiation for GBM, you cannot participate in this trial.
Eligibility Criteria
This trial is for adults over 18 with a confirmed diagnosis of Grade IV glioblastoma multiforme (GBM) who are candidates for significant tumor resection and have not started chemotherapy or radiation. They must be in good enough health to expect to live at least six more months, able to undergo MRI scans, and meet specific blood test criteria. Women of childbearing age must test negative for pregnancy and agree to birth control; men must also agree to use contraception.Participant Groups
- Glioblastoma Multiforme (GBM)
- Anaplastic Astrocytoma (AA)